Kling Bio Announces Collaboration with Sanofi for Accelerated Discovery of Neutralizing Antibodies
Published on 08/07/2025 at 18:06 | prnewswire.co.uk
Leverages Kling's technology to discover hard-to-find, immuno-functional antibodies from immortalized human B cells Accelerating discovery of first-in-class antibodies to transform disease prevention and treatmentView original content:https://www.prnewswire.co.uk/news-releases/kling-bio-announces-collaboration-with-sanofi-for-accelerated-discovery-of-neutralizing-antibodies-302512499.html
en | boerse | 67962937 |
